UnitedHealth extended its 15-year earnings beat streak in 2024 with $3.3 billion in asset sales, raising questions about ...

While hospital fundamentals remain solid for 2025, BofA expects investor sentiment to weaken in the second half of this year as attention shifts to the longer-term impact. The bill is projected to ...

UnitedHealth stock sinks further on reports it quietly sold stakes in business units to preserve its streak of beating earnings estimates. Wolfe continues to recommend owning UNH shares here.

It is hard to get excited after looking at UnitedHealth Group's (NYSE:UNH) recent performance, when its stock has declined 50 ...

Shares have cratered since April, when the company slashed its financial guidance and posted earnings that missed ...

Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...

UnitedHealth continues to face headwinds due to regulatory scrutiny, Medicare costs, and management changes. Read more on ...

UnitedHealth kicked off the year with a stark warning. In early January, management told investors to brace for rising ...

UnitedHealth's management has already signaled an improving outlook for the second half of 2025. Click here to read an ...

UnitedHealth Group is juggling regulatory headaches and financial setbacks while trying to pivot back to stability and growth ...

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group( UNH ...

A significant trading signal occurred for UnitedHealth stock, as it demonstrated a power inflow at $299.78, after which UNH ...